Sarah J. Schlesinger
Director, ARIAD Pharmaceuticals.
Companies
- Armata Pharmaceuticals, Inc.Board member Feb 14, 2020 to now1
- Innoviva, Inc.Board member Feb 14, 2018 to now2
- ARIAD PharmaceuticalsBoard member Jul 17, 2013 to Feb 16, 20173
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Innoviva, Inc. INVA140,492 shares4$3.0M at $21.07May 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 4, 2026Granted 9,786 shares of Innoviva, Inc.4
- May 19, 2025Granted 12,077 shares of Innoviva, Inc.5
- Jun 17, 2024Granted 13,923 shares of Innoviva, Inc.6
- May 22, 2023Granted 16,495 shares of Innoviva, Inc.7
- Apr 25, 2022Granted 12,647 shares of Innoviva, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARInnoviva, Inc., Board member
- 3SEC EDGARARIAD Pharmaceuticals, Board member
- 4
- 5SEC EDGARForm 4 filed May 21, 2025
- 6SEC EDGARForm 4 filed Jun 20, 2024
- 7SEC EDGARForm 4 filed May 24, 2023
- 8SEC EDGARForm 4 filed Apr 27, 2022